Hossein Khalili

InstitutionTehran University of Medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 22 Covid-19 publications, with a maximum of 7 publications in August 2020
    All Publications
    Bar chart showing 150 publications over 15 distinct years, with a maximum of 29 publications in 2012
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Khalili H, Price SL. From uniprofessionality to interprofessionality: dual vs dueling identities in healthcare. J Interprof Care. 2021 Jun 18; 1-6. PMID: 34139953.
      Citations:    Fields:    
    2. SeyedAlinaghi S, Abbasian L, Solduzian M, Ayoobi Yazdi N, Jafari F, Adibimehr A, Farahani A, Salami Khaneshan A, Ebrahimi Alavijeh P, Jahani Z, Karimian E, Ahmadinejad Z, Khalili H, Seifi A, Ghiasvand F, Ghaderkhani S, Rasoolinejad M. Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study. Eur J Med Res. 2021 May 06; 26(1):41. PMID: 33957992.
      Citations: 7     Fields:    Translation:Humans
    3. Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 04 27; 325(16):1620-1630. PMID: 33734299.
      Citations: 78     Fields:    Translation:Humans
    4. Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, Baghizadeh E, Matin S, Jamalkhani S, Tahamtan O, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Khalili H, Yadollahzadeh M, Riahi T, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Amin A, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Dobesh PP, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan; 122(1):131-141. PMID: 33865239.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    5. Mokhtari M, Mohraz M, Gouya MM, Namdari Tabar H, Tabrizi JS, Tayeri K, Aghamohamadi S, Rajabpoor Z, Karami M, Raeisi A, Rahmani H, Khalili H. Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. Int Immunopharmacol. 2021 Jul; 96:107636. PMID: 34015598.
      Citations: 3     Fields:    Translation:Humans
    6. Davoudi-Monfared E, Khalili H. Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19". Antimicrob Agents Chemother. 2021 03 18; 65(4). PMID: 33558288.
      Citations:    Fields:    Translation:Humans
    7. Jafari S, Tabary M, Eshraghi S, Araghi F, Aryannejad A, Mohammadnejad E, Rasoolinejad M, Hajiabdolbaghi M, Koochak HE, Ahmadinejad Z, Abbasian L, Manshadi SAD, Salehi M, Khalili H, Yazdi NA, Seifi A. CT-scan findings of COVID-19 pneumonia based on the time elapsed from the beginning of symptoms to the CT imaging evaluation: a descriptive study in Iran. Rom J Intern Med. 2020 Dec 01; 58(4):242-250. PMID: 32726296.
      Citations:    Fields:    Translation:Humans
    8. Khalili H, Nourian A, Ahmadinejad Z, Emadi Kouchak H, Jafari S, Dehghan Manshadi SA, Rasolinejad M, Kebriaeezadeh A. Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19; A randomized clinical trial. Acta Biomed. 2020 11 10; 91(4):e2020102. PMID: 33525212.
      Citations: 4     Fields:    Translation:Humans
    9. Bikdeli B, Talasaz AH, Rashidi F, Sharif-Kashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, Dabbagh A, Beigmohammadi MT, Payandemehr P, Yadollahzadeh M, Riahi T, Khalili H, Jamalkhani S, Rezaeifar P, Abedini A, Lookzadeh S, Shahmirzaei S, Tahamtan O, Matin S, Amin A, Parhizgar SE, Jimenez D, Gupta A, Madhavan MV, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Mohebbi B, Piazza G, Kirtane AJ, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res. 2020 12; 196:382-394. PMID: 32992075.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    10. Rahmani H, Davoudi-Monfared E, Nourian A, Nabiee M, Sadeghi S, Khalili H, Abbasian L, Ghiasvand F, Seifi A, Hasannezhad M, Ghaderkhani S, Mohammadi M, Yekaninejad MS. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. Daru. 2020 Dec; 28(2):625-634. PMID: 32857301.
      Citations: 4     Fields:    Translation:Humans
    11. Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiol. 2020 09; 15:1287-1305. PMID: 32851877.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    12. Lackie K, Najjar G, El-Awaisi A, Frost J, Green C, Langlois S, Lising D, Pfeifle AL, Ward H, Xyrichis A, Khalili H. Interprofessional education and collaborative practice research during the COVID-19 pandemic: Considerations to advance the field. J Interprof Care. 2020 Sep-Oct; 34(5):583-586. PMID: 32838595.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    13. Rahmani H, Davoudi-Monfared E, Nourian A, Khalili H, Hajizadeh N, Jalalabadi NZ, Fazeli MR, Ghazaeian M, Yekaninejad MS. Interferon ß-1b in treatment of severe COVID-19: A randomized clinical trial. Int Immunopharmacol. 2020 Nov; 88:106903. PMID: 32862111.
      Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
    14. Khalili H, Xyrichis A. A longitudinal survey on the impact of the COVID-19 pandemic on interprofessional education and collaborative practice: a study protocol. J Interprof Care. 2020 Sep-Oct; 34(5):691-693. PMID: 32835552.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    15. Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L, Kazemzadeh H, Yekaninejad MS. A Randomized Clinical Trial of the Efficacy and Safety of Interferon ß-1a in Treatment of Severe COVID-19. Antimicrob Agents Chemother. 2020 08 20; 64(9). PMID: 32661006.
      Citations: 96     Fields:    Translation:HumansCellsPHPublic Health
    16. Langlois S, Xyrichis A, Daulton BJ, Gilbert J, Lackie K, Lising D, MacMillan K, Najjar G, Pfeifle AL, Khalili H. The COVID-19 crisis silver lining: interprofessional education to guide future innovation. J Interprof Care. 2020 Sep-Oct; 34(5):587-592. PMID: 32811213.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    17. Khalili H. Online interprofessional education during and post the COVID-19 pandemic: a commentary. J Interprof Care. 2020 Sep-Oct; 34(5):687-690. PMID: 32674721.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    18. Dashti-Khavidaki S, Mohammadi K, Khalili H, Abdollahi A. Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19. Expert Opin Pharmacother. 2020 Oct; 21(15):1813-1819. PMID: 32659126.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    19. Dashti-Khavidaki S, Khalili H, Nourian A. Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review. Iran J Kidney Dis. 2020 07; 14(4):247-255. PMID: 32655019.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    20. Nourian A, Khalili H. Sofosbuvir as a potential option for the treatment of COVID-19. Acta Biomed. 2020 May 11; 91(2):236-238. PMID: 32420958.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    21. Dashti-Khavidaki S, Khalili H. Considerations for Statin Therapy in Patients with COVID-19. Pharmacotherapy. 2020 05; 40(5):484-486. PMID: 32267560.
      Citations: 40     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Khalili's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (221)
    Explore
    _
    Co-Authors (138)
    Explore
    _
    Similar People (60)
    Explore
    _